UK Drug Discovery Informatics Market Size & Outlook
UK drug discovery informatics market, 2018-2030 (US$M)
Related Markets
UK drug discovery informatics market highlights
- The UK drug discovery informatics market generated a revenue of USD 233.4 million in 2024 and is expected to reach USD 496.2 million by 2030.
- The UK market is expected to grow at a CAGR of 13.4% from 2025 to 2030.
- In terms of segment, sequence analysis platforms was the largest revenue generating service in 2024.
- Sequence Analysis Platforms is the most lucrative service segment registering the fastest growth during the forecast period.
Drug discovery informatics market data book summary
| Market revenue in 2024 | USD 233.4 million |
| Market revenue in 2030 | USD 496.2 million |
| Growth rate | 13.4% (CAGR from 2025 to 2030) |
| Largest segment | Sequence analysis platforms |
| Fastest growing segment | Sequence Analysis Platforms |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
| Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
Other key industry trends
- In terms of revenue, UK accounted for 6.4% of the global drug discovery informatics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany drug discovery informatics market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 536.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 41.47% in 2024. Horizon Databook has segmented the UK drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
UK biotechnology and health care system complements the translational research expertise in NIHR Biomedical Research Centers and Units with the adoption of technology involved through Academic Health Science Centers (AHSCs).
United Kingdom is expected to grow in tandem with the overall European market over the forecast period owing to the favourable government policies and increasing adoption rates of informatic platforms by the prominent market participants.
Moreover, use of clinical data informatics platforms by productive research collaborations in the industry is anticipated to propel sector growth in the coming years.
Reasons to subscribe to UK drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK drug discovery informatics market , including forecasts for subscribers. This country databook contains high-level insights into UK drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK drug discovery informatics market size, by service, 2018-2030 (US$M)
UK Drug Discovery Informatics Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
